FAS-Dependent Cell Death in α-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kragh, Christine L ^a   Fillon, Gwenaëlle ^b,j   Gysbers, Amanda ^c   Hansen, Hanne D ^d,k   Neumann, Manuela ^e   Richter Landsberg, Christiane ^f   Haass, Christian ^b   Zalc, Bernard ^g   Lubetzki, Catherine ^g   Gai, Wei Ping ^h   Halliday, Glenda M ^c   Kahle, Philipp J ^d,i   Jensen, Poul H ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f UNIVERSITY OF OLDENBURG   (Germany)

^g INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^h FLINDERS UNIVERSITY   (Australia)

ⁱ GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^j F HOFFMANN LA ROCHE LTD   (Switzerland)

^k Rigshospitalet   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIGEN; PROTEIN P25; PROTEIN P25 ALPHA; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; MOLECULAR PATHOLOGY; MOUSE; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SHY DRAGER SYNDROME;

AGED; ALPHA-SYNUCLEIN; ANIMALS; ANTIGENS, CD95; BRAIN; CELL DEATH; FAS LIGAND PROTEIN; GENE EXPRESSION; HUMANS; MICE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; SIGNAL TRANSDUCTION;

MUS MUSCULUS; PARKINSONIA; RATTUS;

EID: 84872833651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055243     Document Type: Article

References (40)

1. Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, et al. (1998) Immunoelectron-microscopic demonstration of NACP/alpha-synuclein- epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808: 93-100.
2. Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, et al. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44: 415-422.
3. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H, (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy 2. NeurosciLett 249: 180-182.
4. Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, et al. (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. Embo Reports 3: 583-588.
5. Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, et al. (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration 4. Neuron 45: 847-859.
6. Shults CW, Rockenstein E, Crews L, Adame A, Mante M, et al. (2005) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. JNeurosci 25: 10689-10699.
7. Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, et al. (2005) Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. AmJPathol 166: 869-876.
8. Ubhi K, Lee PH, Adame A, Inglis C, Mante M, et al. (2009) Mitochondrial Inhibitor 3-Nitroproprionic Acid Enhances Oxidative Modification of Alpha-synuclein in a Transgenic Mouse Model of Multiple System Atrophy. Journal of Neuroscience Research 87: 2728-2739.
9. Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, et al. (2007) p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. AmJPathol 171: 1291-1303.
10. Wakabayashi K, Takahashi H, (2006) Cellular pathology in multiple system atrophy 1. Neuropathology 26: 338-345.
11. Yoshida M, (2007) Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 27: 484-493.
12. Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, et al. (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30: 6236-6246.
13. Nakayama K, Suzuki Y, Yazawa I, (2009) Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy. Am J Pathol 174: 1471-1480.
14. Strasser A, Jost PJ, Nagata S, (2009) The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
15. Choi C, Benveniste EN, (2004) Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 44: 65-81.
16. Hovelmeyer N, Hao ZY, Kranidioti K, Kassiotis G, Buch T, et al. (2005) Apoptosis of oligodendrocytes via fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis 1. Journal of Immunology 175: 5875-5884.
17. Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, et al. (2005) p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. JBiolChem 280: 5703-5715.
18. Richter-Landsberg C, Heinrich M, (1996) OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures 1. JNeurosciRes 45: 161-173.
19. Kragh CL, Lund LB, Febbraro F, Hansen HD, Gai WP, et al. (2009) {alpha}-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells. J Biol Chem 284: 10211-10222.
20. Lubetzki C, Goujet-Zalc C, Gansmuller A, Monge M, Brillat A, et al. (1991) Morphological, biochemical, and functional characterization of bulk isolated glial progenitor cells. J Neurochem 56: 671-680.
21. Chowdhury I, Tharakan B, Bhat GK, (2006) Current concepts in apoptosis: the physiological suicide program revisited. Cell MolBiolLett 11: 506-525.
22. Muzio M, (1998) Signalling by proteolysis: death receptors induce apoptosis 3. International Journal of Clinical & Laboratory Research 28: 141-147.
23. Skjoerringe T, Lundvig DM, Jensen PH, Moos T, (2006) P25alpha/Tubulin polymerization promoting protein expression by myelinating oligodendrocytes of the developing rat brain. JNeurochem 99: 333-342.
24. Goldbaum O, Jensen PH, Richter-Landsberg C, (2008) The expression of tubulin polymerization promoting protein TPPP/p25alpha is developmentally regulated in cultured rat brain oligodendrocytes and affected by proteolytic stress. Glia 56: 1736-1746.
25. Kovacs GG, Gelpi E, Lehotzky A, Hoftberger R, Erdei A, et al. (2007) The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol 113: 153-161.
26. Lehotzky A, Lau P, Tokesi N, Muja N, Hudson LD, et al. (2010) Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation. Glia 58: 157-168.
27. Lantos PL, (1998) The definition of multiple system atrophy: a review of recent developments. JNeuropatholExpNeurol 57: 1099-1111.
28. Kahle PJ, Haass C, Kretzschmar HA, Neumann M, (2002) Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases. JNeurochem 82: 449-457.
29. Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, et al. (2000) Subcellular localization of wild-type and Parkinson's disease- associated mutant alpha-synuclein in human and transgenic mouse brain. JNeurosci 20: 6365-6373.
30. Schneider P, Holler N, Bodmer J-L, Hahne M, Frei K, et al. (1998) Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187: 1205-1213.
31. Jodo S, Xiao S, Hohlbaum A, Strehlow D, Marshak-Rothstein A, et al. (2001) Apoptosis-inducing membrane vesicles. A novel agent with unique properties. J Biol Chem 276: 39938-39944.
32. O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, et al. (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131: 1362-1372.
33. Tong J, Wong H, Guttman M, Ang LC, Forno LS, et al. (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain 133: 172-188.
34. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, et al. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184: 2361-2370.
35. Stemberger S, Poewe W, Wenning GK, Stefanova N, (2010) Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol 224: 459-464.
36. Ackery A, Robins S, Fehlings MG, (2006) Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury 1. Journal of Neurotrauma 23: 604-616.
37. Fehlings M, Robins-Steele S (2012) The delayed post-injury administration of soluble Fas receptor attenuates post-traumatic neural degeneration and enhances functional recovery after traumatic cervical spinal cord injury. Journal of neurotrauma.
38. Ahmed Z, Asi YT, Lees AJ, Revesz T, Holton JL (2012) Identification and Quantification of Oligodendrocyte Precursor Cells in Multiple System Atrophy, Progressive Supranuclear Palsy and Parkinson's Disease. Brain Pathol.
39. Kholodilov NG, Neystat M, Oo TF, Lo SE, Larsen KE, et al. (1999) Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. J Neurochem 73: 2586-2599.
40. Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, et al. (2004) Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 279: 46415-46423.